Welcome - Home - Register - Login - Help/FAQ - 0 items

Search Enter keywords, a title or a report id number below. In All Categories --------------------- Telecom & Computing Business & Finance Mfg & Construction Pharma & Healthcare Consumer & Retail Gov & Public Sector Energy & Transport Country Reports Company Reports --------------------- Transcripts Advanced      Select a currency for use throughout the site Australia Dollars Canada Dollars Euro Japan Yen Sweden Kroner Switzerland Francs UK Pounds US Dollars Viewing report Order by Fax Printer Friendly PDF Brochure Send to Friend Enquire before Buying Hard Copy Electronic Site License Breast Cancer Insight - Defining Drug Decisions - How Can Companies Influence the Treatment of Breast Cancer? Datamonitor, April 2002, Pages: 548   Description     Table of Contents        Enquire before Buying    Send to a Friend   Based on extensive interviews with breast cancer-treating specialists in the seven major markets, Breast Cancer Insight is a barometer of physicians’ perceptions and prescribing trends. The quantitative and qualitative nature of the Breast Cancer Insight study data provides a full and impartial perspective on the breast cancer market.Over 580 interviews with practising cancer specialists - oncologist,surgeons, radiologists, and gynecologistsRespondents in the 7 major markets - 101 in the USA, and 80 in each of France, Germany, Italy, Spain, UK, and JapanInvestigation of screening and diagnosis techniquesFocus on therapy types: chemotherapies, hormonals, innovatives and adjunct therapiesAnalysis and discussion of survey results from each of the 7 major marketsSelective direction of promotional budget will benefit manufacturersMore comprehensive clinical trial data is needed to convince prescribers.Growth in the market is expected to be driven not only by the rising incidence of breast cancer, but also by the increasing use of chemotherapy in first line treatment.Identify key issues for practicing cancer specialists - the questions they really want the pharma industry to answerExplore the reasons, rational and emotional, behind cancer specialists' decisionsPredict future trends and perception in the treatment of breast cancer patientsPlan new drug development to meet patient management requirements Customers who bought this item also bought Drug Targets for Breast Cancer Treatment Algorithms 2001 Breast Cancer: Herceptin Falling into Stride Pipeline Insight: Breast Cancer - Complex Combinations of Old and New? Strategic Perspectives 2001: Breast Cancer Cost Analysis Drugs of Tommorow 2002: Breast Cancer Stakeholder Insight: Hormonal Therapies in Breast Cancer Stakeholder Insight: Breast Cancer Chemotherapy Stakeholder Insight: Adjunct Therapies in Breast Cancer

		Top of page

All rights reserved. � Copyright 2008 Research and Markets    Terms and conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster